{"id":"https://openalex.org/W2024914808","doi":"https://doi.org/10.1016/0143-4179(89)90082-6","title":"Bestatin potentiates the antinociception but not the motor dysfunction induced by intracerebrally administered dynorphin-B in mice","display_name":"Bestatin potentiates the antinociception but not the motor dysfunction induced by intracerebrally administered dynorphin-B in mice","alternate_titles":[],"publication_year":1989,"publication_date":"1989-05-01","ids":{"openalex":"https://openalex.org/W2024914808","doi":"https://doi.org/10.1016/0143-4179(89)90082-6","mag":"2024914808","pmid":"https://pubmed.ncbi.nlm.nih.gov/2568600"},"language":"en","primary_location":{"id":"doi:10.1016/0143-4179(89)90082-6","doi":"https://doi.org/10.1016/0143-4179(89)90082-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0143-4179(89)90082-6","pdf_url":null,"source":{"id":"https://openalex.org/S86238769","display_name":"Neuropeptides","issn_l":"0143-4179","issn":["0143-4179","1532-2785"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2024914808"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062513710","display_name":"Takanobu Nakazawa","orcid":"https://orcid.org/0000-0003-4863-1277","observed_orcids":["https://orcid.org/0000-0003-4863-1277"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"T. Nakazawa","raw_affiliation_strings":["Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112582115","display_name":"Masuhiro Ikeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Ikeda","raw_affiliation_strings":["Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-chrome, Tsukuba-shi, Ibaraki 300-26, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-chrome, Tsukuba-shi, Ibaraki 300-26, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086988878","display_name":"Takeru Kaneko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T. Kaneko","raw_affiliation_strings":["Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-chrome, Tsukuba-shi, Ibaraki 300-26, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-chrome, Tsukuba-shi, Ibaraki 300-26, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012079629","display_name":"Kiyomi Yamatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Yamatsu","raw_affiliation_strings":["Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-chrome, Tsukuba-shi, Ibaraki 300-26, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tsukuba Research Laboratories, Eisai Co., Ltd., 1-3 Tokodai 5-chrome, Tsukuba-shi, Ibaraki 300-26, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113257454","display_name":"K. Kitagawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K. Kitagawa","raw_affiliation_strings":["Faculty of Pharmaceutical Science, University of Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Science, University of Tokushima, Japan","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006557735","display_name":"Yoshiaki Kiso","orcid":"https://orcid.org/0000-0002-7877-8221","observed_orcids":["https://orcid.org/0000-0002-7877-8221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Kiso","raw_affiliation_strings":["Kyoto College of Pharmacy Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto College of Pharmacy Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5062513710"],"corresponding_institution_ids":["https://openalex.org/I55881946"],"apc_list":{"value":3530,"currency":"USD","value_usd":3530},"apc_paid":null,"fwci":0.5033,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.52117408,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"13","issue":"4","first_page":"277","last_page":"283"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ubenimex","display_name":"bestatin","score":0.8640000224113464},{"id":"https://openalex.org/keywords/dynorphin-b","display_name":"dynorphin B","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antinociception","display_name":"antinociception","score":0.9629999995231628},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.9520000219345093},{"id":"https://openalex.org/keywords/aminopeptidase-inhibition","display_name":"aminopeptidase inhibition","score":0.8140000104904175},{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.8600000143051147},{"id":"https://openalex.org/keywords/intracerebral-administration","display_name":"intracerebral administration","score":0.7910000085830688}],"concepts":[{"id":"https://openalex.org/C151077648","wikidata":"https://www.wikidata.org/wiki/Q324076","display_name":"Dynorphin","level":5,"score":0.7808173894882202},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41141843795776367},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.37450581789016724},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3493170440196991},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3407704830169678},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.2994023859500885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19808951020240784},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.1556193232536316},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.1310734748840332},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.047964513301849365}],"mesh":[{"descriptor_ui":"D000626","descriptor_name":"Aminopeptidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000698","descriptor_name":"Analgesia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004399","descriptor_name":"Dynorphins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004399","descriptor_name":"Dynorphins","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004399","descriptor_name":"Dynorphins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004723","descriptor_name":"Endorphins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004723","descriptor_name":"Endorphins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007276","descriptor_name":"Injections, Intraventricular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007930","descriptor_name":"Leucine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007930","descriptor_name":"Leucine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011930","descriptor_name":"Reaction Time","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0143-4179(89)90082-6","doi":"https://doi.org/10.1016/0143-4179(89)90082-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0143-4179(89)90082-6","pdf_url":null,"source":{"id":"https://openalex.org/S86238769","display_name":"Neuropeptides","issn_l":"0143-4179","issn":["0143-4179","1532-2785"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"journal-article"},{"id":"pmid:2568600","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2568600","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1977610666","https://openalex.org/W1985538179","https://openalex.org/W1990347758","https://openalex.org/W1995587559","https://openalex.org/W2009142791","https://openalex.org/W2020404153","https://openalex.org/W2031632789","https://openalex.org/W2032248898","https://openalex.org/W2035404736","https://openalex.org/W2042916667","https://openalex.org/W2045380850","https://openalex.org/W2066631048","https://openalex.org/W2080376817","https://openalex.org/W2084167599","https://openalex.org/W2086746485","https://openalex.org/W2088637181","https://openalex.org/W2089215875","https://openalex.org/W2093848458","https://openalex.org/W2163556813","https://openalex.org/W2240782410","https://openalex.org/W2318541612","https://openalex.org/W2401188729","https://openalex.org/W4246754643","https://openalex.org/W6658205302"],"related_works":["https://openalex.org/W1985538179","https://openalex.org/W2046161372","https://openalex.org/W2020404153","https://openalex.org/W2163556813","https://openalex.org/W2062112008","https://openalex.org/W1998220343","https://openalex.org/W2318885873","https://openalex.org/W1980623360","https://openalex.org/W2053725870","https://openalex.org/W2332965690"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2024914808","counts_by_year":[{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
